Likewise, ubiquitin fusion degradation protein 1 (UFD1) is also reported to be increased in postmortem CSF analysis and has been put forward as a serum biomarker for the early diagnosis of TIA and ischemic stroke [24,25]. Here, UFD1 is linked to transient ischemic attack.